Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

Theodore Pincus, MD, FACR, MACR

Rush University Medical Center
Chicago, Illinois, United States

Dr. Pincus is Professor of Medicine at Rush University, having served on faculties at Cornell, Stanford, University of Pennsylvania, Vanderbilt, and NYU. His career focus has been pragmatic clinical measurement: a radioimmunoassay for DNA antibodies in systemic lupus erythematosus (1969); genes that control mouse retrovirus infection (1971); severe functional declines and premature death in rheumatoid arthritis (RA), predicted most significantly by patient physical function scores and low socioeconomic status (1984); a 28 joint cou nt for RA (1989), the first "add-on" clinical trial for RA patients with incomplete methotrexate responses (1995), early methotrexate and 3 mg prednisone to improve RA outcomes considerably (2005); a quantitative patient self-report MDHAQ (multidimensional health assessment questionnaire) for routine of all diseases (1993-2006), with four indices within one document : RAPID3 (routine assessment of patient index data) is informative in all rheumatic diseases (2008); FAST4 (fibromyalgia assessment screening tool) agrees more than 90% with 2011 revised criteria (2019), MDS2 (MDHAQ depression screen) and MAS2 (MDHAQ anxiety screen) which agree 80% with reference HADS (hospital anxiety and depression scale) and PHQ9 (2021); a physician RheuMetric checklist of 0-10 estimates of inflammation, joint/organ damage, and patient distress (fibromyalgia, depression, etc.) (2017). Dr. Pincus has published more than 500 reports, book chapters, and editorials.

Presentation(s):